» Articles » PMID: 35720640

Interplay Between Exosomes and Autophagy Machinery in Pain Management: State of the Art

Overview
Journal Neurobiol Pain
Date 2022 Jun 20
PMID 35720640
Authors
Affiliations
Soon will be listed here.
Abstract

Despite recent progress regarding inexpensive medical approaches, many individuals suffer from moderate to severe pain globally. The discovery and advent of exosomes, as biological nano-sized vesicles, has revolutionized current knowledge about underlying mechanisms associated with several pathological conditions. Indeed, these particles are touted as biological bio-shuttles with the potential to carry specific signaling biomolecules to cells in proximity and remote sites, maintaining cell-to-cell communication in a paracrine manner. A piece of evidence points to an intricate relationship between exosome biogenesis and autophagy signaling pathways at different molecular levels. A close collaboration of autophagic response with exosome release can affect the body's hemostasis and physiology of different cell types. This review is a preliminary attempt to highlight the possible interface of autophagy flux and exosome biogenesis on pain management with a special focus on neuropathic pain. It is thought that this review article will help us to understand the interplay of autophagic response and exosome biogenesis in the management of pain under pathological conditions. The application of therapies targeting autophagy pathway and exosome abscission can be an alternative strategy in the regulation of pain.

Citing Articles

Xenogeneic Transplantation Promoted Human Exosome Sequestration in Rat Specific Organs.

Mobarak H, Mahdipour M, Ghaffari-Nasab A, Rahbarghazi R Adv Pharm Bull. 2024; 14(2):426-433.

PMID: 39206404 PMC: 11347747. DOI: 10.34172/apb.2024.022.


Tumoricidal properties of thymoquinone on human colorectal adenocarcinoma cells via the modulation of autophagy.

Moulana M, Haiaty S, Bazmani A, Shabkhizan R, Moslehian M, Sadeghsoltani F BMC Complement Med Ther. 2024; 24(1):132.

PMID: 38532470 PMC: 10964622. DOI: 10.1186/s12906-024-04432-2.


Neuropathic pain; what we know and what we should do about it.

Smith P Front Pain Res (Lausanne). 2023; 4:1220034.

PMID: 37810432 PMC: 10559888. DOI: 10.3389/fpain.2023.1220034.


Cell-free therapy based on extracellular vesicles: a promising therapeutic strategy for peripheral nerve injury.

Namini M, Daneshimehr F, Beheshtizadeh N, Mansouri V, Ai J, Jahromi H Stem Cell Res Ther. 2023; 14(1):254.

PMID: 37726794 PMC: 10510237. DOI: 10.1186/s13287-023-03467-5.


Physiological and pathological consequences of exosomes at the blood-brain-barrier interface.

Salimi L, Seyedaghamiri F, Karimipour M, Mobarak H, Mardi N, Taghavi M Cell Commun Signal. 2023; 21(1):118.

PMID: 37208741 PMC: 10199515. DOI: 10.1186/s12964-023-01142-z.


References
1.
Chen H, Hu Y, Xie K, Chen Y, Wang H, Bian Y . Effect of autophagy on allodynia, hyperalgesia and astrocyte activation in a rat model of neuropathic pain. Int J Mol Med. 2018; 42(4):2009-2019. PMC: 6108883. DOI: 10.3892/ijmm.2018.3763. View

2.
Huang H, Chen L, Zhang H, Li S, Liu P, Zhao T . Autophagy Promotes Peripheral Nerve Regeneration and Motor Recovery Following Sciatic Nerve Crush Injury in Rats. J Mol Neurosci. 2016; 58(4):416-23. PMC: 4829621. DOI: 10.1007/s12031-015-0672-9. View

3.
Liao M, Lu K, Hsu J, Lee C, Cheng M, Ro L . The Role of Autophagy and Apoptosis in Neuropathic Pain Formation. Int J Mol Sci. 2022; 23(5). PMC: 8910267. DOI: 10.3390/ijms23052685. View

4.
Yousuf M, Shiers S, Sahn J, Price T . Pharmacological Manipulation of Translation as a Therapeutic Target for Chronic Pain. Pharmacol Rev. 2020; 73(1):59-88. PMC: 7736833. DOI: 10.1124/pharmrev.120.000030. View

5.
Henne W, Buchkovich N, Emr S . The ESCRT pathway. Dev Cell. 2011; 21(1):77-91. DOI: 10.1016/j.devcel.2011.05.015. View